Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

New information is constantly being learned about the novel coronavirus, COVID-19. These slides will cover the current interim guidance from the Department of Health and Human Services regarding the known risk factors for severe illness or hospitalization due to COVID-19 and how to support people who are infected with HIV.

Activity Summary:

Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know in 5-minutes’ videos from data presented at the 27th Conference on Retroviruses and Opportunistic Infections in Boston, Massachusetts.

Activity Summary:
The Simply Speaking Hepatitis lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Achieving a sustained virologic response (SVR) is expected to benefit nearly all persons with chronic HCV infection. Despite the recommendation for treatment of nearly all patients with HCV infection, it remains critical for clinicians to understand patient- and disease-related factors that place individuals at risk for HCV-related complications as well as for HCV transmission. It is important that clinicians recognize the unique dimensions of HCV disease and its natural history in these populations when considering HCV regimen options. These slides will use a case-based format to review the contemporary management of HCV infection before and after the cure in treatment-naïve and experienced patients with various comorbidities.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from October through December 2019 will discuss recent data from IDWeek, EACS and recent guideline updates to include HIV treatment considerations and complications.

Activity Summary:
Non-alcoholic steatohepatitis (NASH) is a growing cause of cirrhosis, HCC, and liver transplantation. Treatment options for NASH remain limited. Management of NASH typically focuses on treating liver disease and associated metabolic comorbidities. However, no single treatment approach has proved universally applicable to the general population with NASH. Given the biologic complexity of NASH and its heterogeneity, it is unlikely that only one drug will be sufficient to treat all patients.

These educational Conversations in NASH will discuss the current and future burden of disease due to NASH, the potential noninvasive testing modalities for diagnosis and staging of disease, important management considerations, and the latest clinical data for the treatment of NASH.

Activity Summary:
Effective strategies for rheumatoid arthritis (RA) continue to evolve and clinicians are often challenged when presented with clinical scenarios not adequately addressed by current treatment guidelines. Many times treatment decisions necessitate consideration of the most recent clinical trial data.

These educational Clinical Clips will highlight important advances in the medical management of patients with RA based on data presented at the 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting in Atlanta, GA, November 8-13, 2019 through a series of three ‘what you need to know in 5-minutes’ videos.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

This educational Clinical Clip will spotlight the latest advances in the prevention and treatment of HIV and related comorbidities with a series of ‘what you need to know in 5 minutes’ videos from data presented at the 17th European AIDS Conference in Basel, Switzerland.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from July through September, 2019, will discuss recent data on HIV treatment considerations, complications, and future treatment options.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

This educational Clinical Clip will spotlight the latest advances in the prevention and treatment of HIV and related comorbidities with a ‘what you need to know in 10 minutes’ video from data presented at IDWeek 2019 in Washington, DC.

Activity Summary:
Recognizing and discussing significant developments and strategies in ART places healthcare professionals at the forefront of HIV care. New frontiers for HIV therapy continue to be explored, as underscored by evolving regimen principles and the development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Conversations in HIV activity will discuss recent data on special considerations in selecting ART for a patient, dual ART therapy and potential future ART.

Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Recognizing and discussing significant developments and strategies in ART places healthcare professionals at the forefront of HIV care. This activity will explain how recent study results presented at the 10th IAS Conference relate to clinical practice and will discuss significant developments and strategies in the management of persons with HIV. Included topics are HIV prevention, engagement in care, ART trials and new agents, adverse events and pregnancy.

Activity Summary:
Chronic immune thrombocytopenia (ITP) is one of the most common causes of thrombocytopenia in adults. Diagnosis of ITP remains one of exclusion, and differential diagnosis with secondary forms is crucial to exclude other forms of thrombocytopenia, which may require a different therapeutic approach. Furthermore, chronic symptomatic ITP necessitates second-line treatments based on highly individualized considerations. Advances in the understanding of the pathogenesis have led to novel therapeutic targets, such as the thrombopoietin receptor agonists to aid in this personalized approach.

These educational Mini Modules will outline recent data on current and emerging treatment options for chronic ITP, including FcRn and spleen tyrosine kinase inhibitors.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Although stringent remission, or at least low disease activity, is the primary goal of RA therapy, many patients do not reach this target. The pathogenesis of RA non-responders remains unidentified and more research is needed to tie the epigenetic, environmental, and therapeutic factors together to optimize treatment response. To this end, development of new therapeutic approaches is an active area of research.

This activity will discuss potential drug targets, clinical needs/limitations of current RA therapy, data of new agents in late-stage clinical development, and the potential impact of new drugs on future management of RA patients.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of HIV and related comorbidities through a series of ‘what you need to know in 5 minutes’ videos from data presented at the 10th IAS Conference on HIV Science in Mexico City.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from April through June, 2019, will discuss recent data on HIV testing recommendations, HIV treatment and potential complications.

Activity Summary:
The Simply Speaking Rheumatoid Arthritis lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Effective strategies for RA continue to evolve, with many clinical scenarios that are not specifically/adequately addressed by current treatment guidelines. Treatment decisions also necessitate consideration of the most recent clinical trial data. Awareness of advances in RA knowledge base place healthcare professionals at the forefront of RA care. This activity will explain how recent study results in RA apply to clinical practice; discuss significant developments and strategies in RA pathogenesis, measurement, and therapy; and discuss results from key clinical studies on existing and investigational RA agents.

Activity Summary:
The Simply Speaking HIV Prevention lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

PrEP is a proven safe and effective adjunctive tool for the primary prevention of HIV infection in the United States. The uptake of PrEP has seen a steady increase since its introduction. Much of this early success is a result of recognizing key lessons learned from clinical trials and demonstration projects. However, it is estimated that only 15% of those who would benefit from PrEP are receiving it. This activity will discuss the lessons learned from demonstration projects and open-label extension studies on approaches to mitigate potential barriers to PrEP uptake and strategies to improve integration of PrEP into existing clinical practices.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

There continues to be much misunderstanding, misinformation, stigma, and discrimination suffered by marginalized persons with HIV. This activity will use a case-based approach to discuss contemporary HIV management considerations in a number of scenarios, including pregnancy, HCV coinfection, incarceration, substance use disorders, chem sex, transgender, and mental health concerns.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking HIV Prevention lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Reducing HIV transmission remains a major public health goal. HIV testing is the critical first step in making persons aware of their HIV status. Moreover, linking and retaining persons with HIV in care plays a major role in mitigating the risk of HIV transmission. This activity discusses the evolving epidemiology of HIV infection in the United States, recommended approaches to HIV screening, and strategies to link and retain persons with HIV in care.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking Hepatitis lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Recent advances in HCV treatment offer an unprecedented opportunity to eliminate HCV. Scaling up HCV treatment in persons who inject drugs (PWIDs) is necessary to positively impact the HCV epidemic in the US and globally. In addition, to eliminate HCV, there is a need to engage the criminal justice system by increasing routine screening and improving access to direct-acting antiviral agents to persons who are imprisoned. These slides will address important issues for PWIDs and the incarcerated with HCV, including epidemiologic trends, prevention strategies, and AASLD recommendations for contemporary HCV management approaches/challenges and harm reduction approaches.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking HIV Prevention lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Once diagnosed, youth with HIV are the least likely out of any age group to be linked to care and achieve viral suppression once on ART. This program will discuss HIV epidemiologic trends among adolescents, awareness/perceptions of HIV and prevention, counseling needs/challenges for those at risk, and PrEP/treatment considerations.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking Hepatitis lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Critical to achieving the elimination of HCV infection is identifying infected persons with improved screening and surveillance approaches and linking them to HCV care and treatment. These steps will reduce the incidence of HCV, cirrhosis, HCC, liver-related deaths, and retransmission of HCV. These slides review the changing epidemiology/demographics of HCV infection, burden of disease, and discusses screening and linkage-to-care approaches important to achieving the elimination of HCV infection in the United States.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Persistent inflammation is a vexing phenomenon that contributes to comorbidities in persons with HIV as they live longer. Early initiation of ART is the cornerstone to minimizing harmful effects of HIV viremia and inflammation on target organ systems. In addition, greater attention is needed on preventative approaches to mitigate cardiovascular disease, renal insufficiency, bone disease/frailty, and cognitive decline. This activity will use a case-based approach to discuss age-related comorbidities in persons with HIV and prevention/management approaches for HIV and common comorbidities.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking HIV Prevention lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Recognizing and discussing significant developments and strategies in HIV prevention places healthcare professionals at the forefront of HIV prevention and care. This slide set will review data presented at the 2018 HIV Research for Prevention Conference (HIVR4P) such as risk assessment, PrEP trials, new ART and PrEP delivery systems, and an update on vaccine research.

Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Recognizing and discussing significant developments and strategies in ART places healthcare professionals at the forefront of HIV care. This activity will explain how recent study results in ART apply to clinical practice and discuss significant developments and strategies in the management of persons with HIV. Included topics are HIV prevention, engagement in care, ART trials and new agents, adverse events and pregnancy.

Activity Summary:
The Simply Speaking Hepatitis lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Chronic HCV infection affects over 3 million Americans and is a leading cause of liver failure, cirrhosis, and liver cancer. There are an increasing number of young patients and patients with milder disease than described in previous years. Understanding nuances of HCV disease in different patient populations require clinicians to become continually educated on the safe and appropriate use of direct-acting antiviral agents in clinical practice. These slides use a case-based format to discuss the contemporary management of HCV infection before and after the cure in treatment-naïve and experienced patients with various comorbidities.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
We are pleased to have recently held the Atlanta Breast Cancer Symposium (ABCS) on April 13, 2019 at the InterContinental Buckhead in Atlanta, Georgia.

There are multiple professional education opportunities in breast cancer across the country. The difference of the ABCS with others is the emphasis in the molecular basis of breast cancer to be applied from early detection to management of advanced disease, beyond induction treatment.

The objective of the symposium is to educate the oncology community on the rapidly evolving field of breast cancer from molecular biology to the development and clinical application of highly specific molecules to interfere with the cellular machinery allowing the cancer cells to survive, proliferate, and spread.

These certified CME/CE enduring video archives, with panel discussions, provide access to the conference including clinical presentation and interactive panel discussions with the faculty and audience.

We hope you enjoy this activity!

Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

The state-of-the-art approach to HIV management has evolved as regular advances in basic science and clinical research lay the foundation for future trends. This program will review current controversies in the field, including considerations for on-demand PrEP, antiretroviral treatment options for different patient profiles (treatment naïve vs experienced, comorbid conditions and women of child-bearing age), the clinical relevance of recent study results, and other hot topics in HIV clinical management.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from January through March, 2019, will discuss HIV treatment, complications/side effect management and prevention strategies.

Activity Summary:
The national strategy for the elimination of HCV in the United States calls for a 90% reduction incidence of HCV and having 90% of those with HCV being treated. Significant strides have been achieved in simplifying HCV treatment regimens and improving SVR rates. Despite these advances, there are a number of challenging scenarios in HCV that require clinicians to become continually educated on the state-of-the-art approach to HCV management as well as safe and appropriate use of DAA regimens.

These Conversations in HCV will discuss the progress and barriers to achieving HCV elimination, challenging management issues in special patient populations, and strategies for HCV/HIV and HCV/HBV coinfection.